news

The anastomosis production province set to land: the average reduction rate of more than 80%, the domestic market will be a huge change


Release time:

2021-03-09

A few days ago, Jiangsu Province completed the fourth round of medical consumables alliance with quantity procurement negotiations. According to the official results of the negotiations, the average reduction rate of anastomosis reached 83.93% and the highest reduction rate was 96.29%. Jiangsu is the first province to pilot the local collection of high-value medical consumables, with coronary stents as the first shot, and then continuously expanded to a number of other categories such as neurology, ophthalmology, orthopedics, general surgery, etc., and has now completed three rounds of volume procurement.

A few days ago, Jiangsu Province completed the fourth round of medical consumables alliance with quantity procurement negotiations. According to the official results of the negotiations, the average reduction rate of anastomosis reached 83.93% and the highest reduction rate was 96.29%.
Jiangsu is a pioneering province in the local pilot collection of high-value medical consumables, with coronary stents as the first shot, and then continuously expanded to a number of other categories such as neurology, ophthalmology, orthopedics and general surgery, and has now completed three rounds of volume procurement.


Anastomosis is a clinically used alternative to traditional manual suturing equipment, the main working principle is to use titanium staples to dissociate or anastomose tissue, similar to a stapler, the product can be widely used in cardiothoracic surgery, gastrointestinal surgery, hepatobiliary, splenic and pancreatic surgery, general surgery, urology and other surgical fields. According to official statistics, the platform in Jiangsu province is now registered with a total of 112 anastomosis manufacturers, of which 76 have sales of anastomosis, with annual sales of about 1.3 billion yuan.


It is understood that the collection is valued by the industry as Jiangsu is one of the larger provinces in China in terms of clutch usage, plus the province has a concentration of over seventy percent of the country's clutch manufacturers.


"From a costing point of view, business at your own doorstep is always the best value for money." This is what a business person told the KCI Daily at the set-purchase negotiation site on the 30th.


It is worth mentioning that recently, there are rumors in the market that following the first batch of vascular intervention category, non-vascular intervention category, pacemaker category, ophthalmic products, the relevant departments have started the data collection and price monitoring work for the second batch of high-value medical consumables for national procurement, mainly involving artificial hip joints, artificial knee joints, defibrillators, blockers, orthopedic materials, anastomoses and other varieties.


The first batch of coronary stents for vascular intervention was completed in early November, which is also the first national procurement of high-value medical consumables varieties, the market speculation, the next may be in the national procurement of varieties of artificial hip joints, artificial knee joints, defibrillators, blockers, orthopaedic materials, anastomosis several varieties.